EXAMINE THIS REPORT ON SUBUTEX TO SUBOXONE

The concomitant use of buprenorphine and CYP3A4 inducers can reduce the plasma focus of buprenorphine [see CLINICAL PHARMACOLOGY], potentially causing lowered efficacy or onset of a withdrawal syndrome in people who have formulated Actual physical dependence to buprenorphine.This hazard need to be balanced against the potential risk of untreated op